Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Jubilant Life Sciences
Jubilant Life Sciences
Activities:
Manufacturing
Ingredients
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Distribution
Biesterfeld and Jubilant celebrate 25 year partnership on fine chemicals
Biesterfeld Spezialchemie distributes Jubilant Ingrevia’s selected range of products in the field of advanced intermediates to selected customers across Europe
Manufacturing
ON-DEMAND WEBINAR: Delivering the added dimension in Scale-up
Watch Jubilant Biosys' complimentary webinar and live Q&A, hosted in association with Manufacturing Chemist on 7 July, 2020
Delivering the added dimension in Scale-up
7 July 2020 | Webinar
Manufacturing
Jubilant Biosys begins two drug discovery facility expansions in India
The CRO has invested in expansion of the Greater Noida and Bengalaru facilities
Research & Development
Jubilant Biosys strengthens its leadership team with two key appointments
Hires Steven Hutchins as President and Dr Takeshi Yuri as VP of Medicinal Chemistry
Manufacturing
Jubilant Life Sciences to sell licensed and proprietary diabetes and cardiovascular products
Has seen substantial growth in its domestic Indian market with such products
Finance
IFC makes major loan to Jubilant Pharma
To boost generics production
Subscribe now